Posted on: 21 September 2021
An international group of scientists with expertise in developmental biology, biomedical engineering and nanoscience will use a newly secured grant of around €1 million to develop synthetic tendon and ligament implants.
The research is funded by the National Science Foundation (USA), Science Foundation Ireland and the Department for the Economy (Northern Ireland).
Torn ligaments and tendons are the bane of athletes and runners; they are difficult to heal and often require months or years of rehab. Currently, the only fix for severe tears is to remove soft tissues from another part of the patient’s body, or a cadaver, and use them to repair a knee or ankle. This is costly and inefficient, but the medical field has yet to come up with a better solution.
The international group, comprising scientists from Trinity, Queens University Belfast and Penn State University, hopes to change that after securing the funding to support a four-year project.
The group will develop genetically engineered soft tissues modeled on how tendons develop in the embryo, and attempt to improve the production of artificial tendon and ligament replacements by replicating the molecular events that drive embryonic tendon development using nanoparticle delivery and mechanical stimulation of cells grown as “mini tendons” in culture.
To better understand the embryonic development of tendons and ligaments, co-principal investigator Paula Murphy, Professor in Zoology at Trinity, brings expertise in developmental biology where the team will investigate normal tendon development in chick and mouse embryos, and establish gene editing approaches to alter how tendon cells communicate with each other and their environment.
This will test which molecular pathways are essential for the formation of mature tendons. The engineering team in the US will measure the tendons of chicks and mice at different points of development and, together with the Trinity team, will map out the mechanical, structural and biological features at each stage.
The scientists will also investigate the idea that movement inside the egg — like a human baby kicking in the womb — is critical to tendon development.
“Research shows that tendon cells are sensitive to movement and stimulation,” said co-principal investigator Spencer Szczesny, Assistant Professor of Biomedical Engineering at Penn State University.
“We will determine if the muscle stimulation impacts cell behaviour and how they form the tissue around them. Our hypothesis is that muscle activity early on stimulates tendon and ligament cells to grip onto collagen instead of neighboring cells, forming a connection to collagen fibres, which is critical to forming a healthy tendon.”
If that hypothesis proves true, Professor Szczesny will apply mechanical stimulation to cells when creating a tendon implant in the second phase of the project, mimicking what is happening in an egg or a human womb.
In another key part of the project, the researchers will also use nanoparticles to influence tendon growth, essentially “telling” cells to turn certain genes on or off; these genes will have been discovered from the embryonic study.
Co-principal investigator Helen McCarthy, Professor at Queen’s University Belfast, is an expert in nanomaterial drug delivery. She will lead the nanoparticle design, which should mimic the embryonic process by pushing stem cells to release neighbouring cells and bind instead to collagen fibres. If they are successful, the researchers will test the functionality of their new tendon construct in an animal model.
Professor Paula Murphy said:
“This project is truly interdisciplinary, integrating international expertise in biomechanics, mechanobiology, developmental biology and materials science. We are particularly enthusiastic to bring a developmental perspective to understanding tendon biomechanics and to addressing the critical barriers that have – to date – prevented the development of functional load-bearing tendon and ligament replacements.”
Niamh Buckley, senior lecturer in personalised medicine and pharmacogenomics at Queen’s University Belfast; Aman Dhawan, Penn State associate professor of orthopaedics and rehabilitation; and Nicholas Dunne, professor of biomaterials engineering at Dublin City University, will also contribute to the research.
